Early Death May Be Common in Cancer Patients Taking Immune Checkpoint Inhibitors
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
The rising cost of care is having a negative impact on patients with bladder cancer, but a value-based approach to care might provide some relief.
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Tobacco smoking is the most important modifiable factor associated with bladder cancer risk, according to investigators.
Radiation therapy for prostate cancer is significantly associated with more than twice the risk for bladder cancer compared with radical prostatectomy, a study found.
The prevalence of metastatic cancers in the US has risen in recent years and will increase further by 2025, according to researchers.
Investigators sought to determine the efficacy and safety of N-803 plus BCG in patients with high-risk NMIBC.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Men undergoing radical cystectomy are most likely to recover erectile function if they have good function before the surgery and receive nerve-sparing, according to investigators.
HLA-A*03 was associated with worse progression-free and overall survival.